Bio-pharma services are key to our strategy: Novo Holdings CEO

Sdílet
Vložit
  • čas přidán 5. 02. 2024
  • Kasim Kutay, CEO of Novo Holdings, discusses Novo Holdings acquisition of U.S.-based medicines manufacturer Catalent.

Komentáře •